Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · IEX Real-Time Price · USD

14.32

-0.39 (-2.65%)

At close: Jul 19, 2024, 4:00 PM

14.44

+0.12 (0.84%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Enanta Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	2018 - 2010
Revenue	72.88	79.2	86.16	97.07	122.47	205.2	Upgrade
Revenue Growth (YoY)	-10.22%	-8.07%	-11.24%	-20.74%	-40.31%	-0.69%	Upgrade
Gross Profit	72.88	79.2	86.16	97.07	122.47	205.2	Upgrade
Selling, General & Admin	57.17	52.89	45.48	32.54	27.36	26.25	Upgrade
Research & Development	151.11	163.52	164.52	174.11	136.76	142.21	Upgrade
Operating Expenses	208.28	216.41	210	206.65	164.11	168.46	Upgrade
Operating Income	-135.4	-137.21	-123.84	-109.57	-41.64	36.74	Upgrade
Interest Expense / Income	11.15	5.15	0	0	0	0	Upgrade
Other Expense / Income	-16.64	-11.36	-1.66	-1.99	-6.62	-8.82	Upgrade
Pretax Income	-129.91	-131	-122.19	-107.58	-35.02	45.56	Upgrade
Income Tax	1.83	2.82	-0.43	-28.58	1.15	-0.83	Upgrade
Net Income	-131.74	-133.82	-121.76	-79	-36.17	46.38	Upgrade
Net Income Growth	-	-	-	-	-	-35.54%	Upgrade
Shares Outstanding (Basic)	21	21	21	20	20	20	Upgrade
Shares Outstanding (Diluted)	21	21	21	20	20	21	Upgrade
Shares Change	0.63%	1.78%	2.14%	1.16%	-4.90%	1.54%	Upgrade
EPS (Basic)	-6.24	-6.38	-5.91	-3.92	-1.81	2.37	Upgrade
EPS (Diluted)	-6.24	-6.38	-5.91	-3.92	-1.81	2.21	Upgrade
EPS Growth	-	-	-	-	-	-36.49%	Upgrade
Free Cash Flow	-113.29	-112.21	-86.91	-70.75	5.64	66	Upgrade
Free Cash Flow Per Share	-5.35	-5.35	-4.22	-3.51	0.28	3.37	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-185.78%	-173.23%	-143.74%	-112.88%	-34.00%	17.90%	Upgrade
Profit Margin	-180.75%	-168.95%	-141.31%	-81.38%	-29.53%	22.60%	Upgrade
Free Cash Flow Margin	-155.45%	-141.67%	-100.87%	-72.88%	4.61%	32.16%	Upgrade
Effective Tax Rate	-	-	-	-	-	-1.81%	Upgrade
EBITDA	-116.18	-123.48	-119.22	-104.25	-31.38	48.82	Upgrade
EBITDA Margin	-159.40%	-155.90%	-138.36%	-107.39%	-25.62%	23.79%	Upgrade
Depreciation & Amortization	2.58	2.37	2.97	3.33	3.64	3.26	Upgrade
EBIT	-118.76	-125.85	-122.19	-107.58	-35.02	45.56	Upgrade
EBIT Margin	-162.95%	-158.89%	-141.82%	-110.82%	-28.59%	22.20%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).